Sepsis-Induced ARDS Patient Data for GLR Mortality Prediction

A multicenter retrospective cohort study analyzing the glucose-to-lymphocyte ratio (GLR) as a predictor of 28-day mortality in sepsis-induced ARDS patients. The primary cohort includes 2,485 individuals from the MIMIC-IV database, with an external validation cohort of 298 patients from a hospital in China. The dataset was uploaded by Shucun Liu on March 19, 2026.

Use Cases

• Predicting 28-day mortality risk in sepsis-induced ARDS patients based on the glucose-to-lymphocyte ratio.
• Evaluating the incremental prognostic value of GLR over established severity scores like APS III and SAPS II.
• Conducting subgroup analyses to assess GLR's predictive power in patients with varying illness severity or liver disease.
• Training Cox proportional hazards models for short-term mortality using composite biomarkers.
• Performing external validation of biomarker-based risk stratification models.

Strengths

• Includes a primary cohort of 2,485 patients and an independent validation cohort of 298 patients.
• The study demonstrates a statistically significant association between GLR and mortality (adjusted HR 1.13 per unit increase).
• Incorporating GLR improved the AUC of APS III and SAPS II models (APS III: 0.694 vs. 0.708; SAPS II: 0.678 vs. 0.696).

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is very small (20.3 KB), suggesting limited scope or a summary table rather than raw patient records.

Provenance

Source

MIMIC-IV database and Affiliated Hospital of Xuzhou Medical University.

Collection Method

Multicenter retrospective cohort analysis.

Freshness

Last updated 2026-03-19 06:34:35